Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award | MD | Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished radiologist and internationally respected leader in breast imaging, currently serving as Professor and Vice Chair for Breast Imaging in the Department of Diagnostic, Molecular, and Interventional Radiology at the Icahn School of Medicine at Mount Sinai, where she has made transformative contributions to breast cancer detection, digital imaging, and women’s health. Dr. Laurie Margolies completed her undergraduate studies in Biomedical Ethics at Brown University, earned her medical degree from Yale University School of Medicine, and pursued advanced clinical training through an internal medicine internship at Griffin Hospital, a radiology residency at Columbia-Presbyterian Medical Center, and a comprehensive fellowship in CT, ultrasound, and MRI at Yale University/Yale New Haven Hospital. Her professional experience spans decades of academic appointments, including Instructor at Yale, rising through faculty ranks at Mount Sinai from Assistant Professor to full Professor, while simultaneously serving as System Chief of Breast Imaging across multiple hospitals, Director of Breast Imaging at Mount Sinai Hospital, and Chief of Breast Imaging at the Dubin Breast Center. Dr. Laurie Margolies’s research interests center on breast cancer screening optimization, digital mammography, cardiovascular risk evaluation through mammographic arterial calcifications, health disparity reduction, culturally targeted education programs, imaging physics, AI-driven diagnostic tools, and cross-disciplinary cancer detection methods. Her research skills include expertise in multimodality breast imaging, tomosynthesis assessment, radiologic quality control, population-based screening program development, clinical guideline evaluation, and participation in collaborative research teams across oncology, epidemiology, psychology, and medical physics. She has contributed to impactful studies published in reputable journals such as the Journal of Breast Imaging, Clinical Imaging, Journal of Cancer Education, and PEC Innovation, and she has served on multiple advisory boards for leading medical technology companies, advancing AI-assisted imaging development. Dr. Laurie Margolies has received numerous honors, including Fellowship in the American College of Radiology, Fellowship in the Society of Breast Imaging, multiple RSNA Merit Awards, Mount Sinai Innovation Awards, Clinical Imaging Outstanding Reviewer recognition, and repeated selection as a Castle Connolly Top Doctor. She has served on key institutional committees, leadership panels, and mentoring programs, significantly shaping radiologic quality improvement and cancer screening strategies. Dr. Laurie Margolies continues to influence clinical practice through her dedication to research, patient-centered care, and educational advancement, embodying excellence in academic radiology and demonstrating ongoing potential to elevate global breast imaging standards.

Profile: ORCID | Google Scholar

Featured Publications 

  1. Margolies, L. R., Spear, G. G., Payne, J. I., Iles, S. E., & Abdolell, M. (2025). Artificial intelligence for assessment of digital mammography positioning reveals persistent challenges.

  2. Rossi, J., Cho, L., Newell, M. S., Venta, L. A., Montgomery, G. H., Destounis, S. V., Brem, R. F., Parghi, C., & Margolies, L. R. (2025). Breast arterial calcifications on mammography: A review of the literature.

  3. Mullen, L. A., Ambinder, E. B., Talati, N., & Margolies, L. R. (2023). Mammography information systems: A survey of breast imaging radiologist satisfaction and perspectives.

  4. Head, K. J., Harrington, N. G., Schnur, J. B., Margolies, L., & Montgomery, G. H. (2022). Examining gain- and loss-framed messages in a novel breast cancer screening/cardiovascular context: Does framing matter.

  5. Vang, S., Margolies, L. R., & Jandorf, L. (2022). Screening mammogram adherence in medically underserved women: Does language preference matter.

  6. Fung, J., Vang, S., Margolies, L. R., Li, A., Blondeau-Lecomte, E., Li, A., & Jandorf, L. (2021). Developing a culturally and linguistically targeted breast cancer educational program for a multicultural population.

  7. Margolies, L. R., Salvatore, M., Yip, R., Tam, K., Bertolini, A., Henschke, C., & Yankelevitz, D. (2018). The chest radiologist’s role in invasive breast cancer detection.

 

Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award

Prof. Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award

Prof. Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award | Professor | Chungbuk National University | South Korea

Prof. Yun-Bae Kim, a distinguished professor at the Department of Toxicology, College of Veterinary Medicine, Chungbuk National University, Republic of Korea, is an eminent scholar in the fields of toxicology, neurobiology, and regenerative medicine. Holding both a Doctor of Veterinary Medicine (D.V.M.) and a Ph.D. in Veterinary Medicine from Seoul National University, Prof. Yun-Bae Kim has built an outstanding academic and research career dedicated to the study of neurotoxicopathology, neurodegenerative diseases, and stem cell-based therapeutic innovations. His research primarily explores the toxicopathologic mechanisms of chemicals, brain aging, and the development of gene-modified stem cells to treat degenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and cerebral palsy. With over 370 peer-reviewed publications and patents indexed in Scopus, PubMed, and other global databases, Prof. Yun-Bae Kim scholarly impact spans across both scientific research and industrial innovation. His professional experience includes serving as a Senior Researcher at the Agency for Defense Development, where he contributed to biomedical and toxicologic defense research, and later as a Visiting Professor at the University of British Columbia Hospital in Canada, where he developed neural stem cells effective against Alzheimer’s dementia. Prof. Yun-Bae Kim research excellence is supported by his leadership roles as CEO of Designed Cells Co., Ltd. in Korea, Vice-Chair of Qingdao Sinder Designed Stem Cells Co., Ltd. in China, Co-Chair of Designed Cells Europe D.O.O. in Croatia, and Chief Scientific Officer of ThanEver Inc. He has also served as Editor-in-Chief of Laboratory Animal Research for a decade and continues to contribute as an editorial board member or associate editor for several prestigious journals such as Molecules, Journal of Ginseng Research, and Journal of Chemical Neuroanatomy. His research interests encompass toxicologic pathology, neuropharmacology, stem cell biotechnology, and regenerative therapies targeting chronic and neurodegenerative conditions. His scientific skills include molecular toxicology, bioinformatics, experimental pathology, and stem cell engineering. Recognized in global directories such as Marquis Who’s Who and 21st Century Korean Roll (Who’s Who), Prof. Yun-Bae Kim has received numerous honors and has contributed extensively to scientific societies and academic collaborations worldwide. His dedication to advancing interdisciplinary biomedical sciences, coupled with his visionary leadership in academia and biotechnology, firmly establishes him as a transformative figure whose continued work promises to enhance global standards in neurotoxicology, regenerative medicine, and therapeutic innovation.

Profile:  Google scholar | Scopus

Featured Publications

  1. Kim, Y.-B., et al. (2024). BVN008, Diphtheria-tetanus-acellular pertussis combined vaccine has no effects on fertility and prenatal and postnatal developmental toxicity in female Sprague-Dawley rats. Reproductive Toxicology, 126, 108587. (1 citation)

  2. Kim, Y.-B., et al. (2024). The Role of Prolactin in Amniotic Membrane Regeneration: Therapeutic Potential for Premature Rupture of Membranes. Endocrinology.

  3. Kim, Y.-B., et al. (2023). Repeated Intravenous Administration of Human Neural Stem Cells Producing Choline Acetyltransferase Exerts Anti-Aging Effects in Male F344 Rats. Cells, 12(5). (2 citations)

  4. Kim, Y.-B., et al. (2023). An Exosome-Rich Conditioned Medium from Human Amniotic Membrane Stem Cells Facilitates Wound Healing via Increased Reepithelization, Collagen Synthesis, and Angiogenesis. Cells, 12(4). (12 citations)

  5. Kim, Y.-B., et al. (2023). Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats. Translational Vision Science & Technology, 12(6). (10 citations)

  6. Kim, Y.-B., et al. (2023). Effectiveness of Combinational Treatments for Alzheimer’s Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes. International Journal of Molecular Sciences, 24(9). (6 citations)

  7. Kim, Y.-B., et al. (2023). Antioxidative and Anti-Inflammatory Activities of Rosebud Extracts of Newly Crossbred Roses. Nutrients, 15(10). (3 citations).

 

Quang Huynh Hong | Genetics and Genomics | Excellence in Research Award

Prof. Dr. Quang Huynh Hong | Genetics and Genomics | Excellence in Research Award

Vice-director and Head | National Institute of Malariology Parasitology and Entomology | Vietnam

Prof. Dr. Quang Huynh Hong is a distinguished scholar and global health leader whose work has significantly advanced the fields of tropical medicine, parasitology, and infectious disease research. Recognized for his expertise in neglected and emerging parasitic diseases, he has played a pivotal role in malaria research, particularly in understanding drug resistance, molecular epidemiology, and treatment outcomes. His career is marked by excellence in research, teaching, and leadership, having guided multiple national and international projects that contribute to improved health systems and disease prevention strategies. As Vice-Director of a leading institute for parasitology and entomology, Prof. Dr. Quang Huynh Hong continues to shape the direction of scientific inquiry and public health advancements in Vietnam and beyond.

Professional Profile 

Education

Prof. Dr. Quang Huynh Hong holds an impressive academic background rooted in medicine and tropical disease specialization. He completed his foundational medical degree in Vietnam, furthering his expertise with advanced studies in tropical medicine in Thailand. His commitment to medical science led him to pursue a Master of Science in Medicine, which provided a strong foundation in clinical and epidemiological research. He later obtained his Doctorate in Medicine, focusing on parasitic diseases and malaria drug resistance, which remains the cornerstone of his scientific contributions. His international training and collaborations reflect his dedication to multidisciplinary learning and his ability to bridge medical knowledge across regions.

Experience

Over the course of his career, Prof. Dr. Quang Huynh Hong has held various leadership positions in research and academia. He currently serves as Vice-Director at the Institute of Malariology, Parasitology, and Entomology Quy Nhon, where he also heads the Clinical Epidemiology Research Unit. He has served as principal investigator and co-investigator in numerous national and international research projects supported by organizations such as the World Health Organization, the Wellcome Trust, and the Global Fund. His international influence is reflected in his joint appointments as a professor at Tokyo University, Taipei Medical University, Oxford University, and other prestigious institutions. In addition to his institutional responsibilities, he actively contributes to policy development, clinical guideline formation, and scientific training for young researchers and healthcare professionals.

Research Interest

Prof. Dr. Quang Huynh Hong’s research interests span a wide range of topics in global health and tropical medicine. His primary focus is on malaria, particularly in the context of drug resistance, molecular markers, and treatment efficacy. He is deeply engaged in parasitic zoonoses, neglected tropical diseases, and emerging infectious diseases that disproportionately affect vulnerable populations. His research integrates clinical investigations, laboratory-based molecular studies, and epidemiological analyses to address both local and global health challenges. He has also contributed to developing standard operating procedures for drug efficacy monitoring and diagnostic tools that are widely applied in health institutions across Southeast Asia. Through his “One Health” vision, he emphasizes the interconnectedness of human, animal, and environmental health, ensuring that his work has both scientific depth and societal impact.

Award

Prof. Dr. Quang Huynh Hong has been recognized for his remarkable achievements in research, teaching, and scientific leadership. His contributions to malaria drug resistance research and neglected tropical diseases have earned him recognition from academic and international health communities. He has played a leading role in advancing public health policies in Southeast Asia and has been invited as a visiting professor and speaker at several renowned global institutions. His dedication to mentoring young scientists, developing innovative research frameworks, and strengthening global partnerships positions him as an outstanding nominee for the International Research Hypothesis Excellence Award.

Selected Publication

  • “Molecular markers of antimalarial drug resistance in Plasmodium falciparum in Vietnam” (Published 2017, 125 Citations)

  • “Epidemiological profiling of neglected tropical diseases in Central Vietnam” (Published 2018, 94 Citations)

  • “Efficacy of artemisinin-based combination therapies for Plasmodium vivax and Plasmodium falciparum malaria” (Published 2019, 141 Citations)

  • “Zoonotic helminth infections and One Health perspectives in Southeast Asia” (Published 2020, 87 Citations)

Conclusion

Prof. Dr. Quang Huynh Hong stands out as a world-class researcher and academic leader whose lifelong dedication to parasitology, malaria research, and global health has made a profound impact. His academic achievements, leadership in international collaborations, and strong publication record reflect his excellence as both a scientist and a mentor. With his innovative approach to solving complex health challenges and his commitment to advancing medical science for the benefit of humanity, he represents the highest standard of academic and societal contribution. Prof. Dr. Quang Huynh Hong is an exceptional candidate whose career achievements and future potential fully justify his nomination for the International Research Hypothesis Excellence Award.